维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="Fergelot"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Low CAIX expres-sion and absence of VHL gene mutation are associated with tu-mor aggressiveness and poor survival of clear cell renal cellcarcinoma显示文摘	Patard J J Fergelot P KaraKiewicz P I et af	2008	Int J Cancer2008，123，2：	1
2	Prognostic value of thrombocytosis in renal cell carcinoma显示文摘	Bensalah K Leray E Fergelot P	2006	J Urol2006，175，31：	1
3	Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases显示文摘	Rioux-Leclercq N Fergelot P Zerrouki S	2007	I-Ium Pathol2007，38，10：	1
4	Prognostic value of thrombocytosis in renal cell carcinoma显示文摘	Bensalah K Leray E Fergelot P	2006	J Urol2006，175，：	1
5	Low CAIX expres-sion and absence of VHL gene mutation are associated with tu-mor aggressiveness and poor survival of clear cell renal cellcarcinoma显示文摘	Patard J J Fergelot P Karakiewicz P I	2008	Int J Cancer2008，123，2：	1
6	Low CAIX ex pression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell re- nal cell carcinoma显示文摘	Patard J J Fergelot P Karakiewicz PI	2008	Int J Cancer2008，123，2：	1
7	Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma:a prospective study of 50 cases显示文摘	Rioux-Leclercq N Fergelot P Zerrouki-S		0，，10：	1
8	Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells显示文摘	Massart C Poirier C Fergelot P	2005	Anticancer Drugs2005，16，3：	1
9	Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases显示文摘	RIOuX-LECLERCQ N FERGELOT P ZERROUKI S	2007	Hum Pathol2007，38，10：	1
10	Loss of expression of T1MP- 3 in clear cell carcenoma 显示文摘	Masson D Rioux N Fergelot P	2010	Eur J Cancer2010，46，8：	1
11	Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells 显示文摘	MASSART C POIRIER C FERGELOT P	2005	Anticancer Drugs2005，16，3：	1
12	Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival ofclear cell renal cell carcinoma显示文摘	Patard J J Fergelot E Karakiewicz P1	2008	International Journal of Cancer2008，123，2：	1
13	Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases显示文摘	Rioux--Leclercq N Fergelot P Zerrouki-S	2007	Hum Pathol2007，38，10：	1
14	Understanding the importance of smart drugs in renal cell carcinoma显示文摘	Patard JJ Rioux-Leclercq N Fergelot P	2006	Eur Urol2006，49，4：	1
15	Understanding the importance of smart drugs in renal cell carcinoma显示文摘	Patard J J Rioux-Leclercq N Fergelot P	2006	Eur Urol2006，49，4：	1
16	Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases 显示文摘	Rioux - Leclercq N Fergelot P Zerrouki S	2007	Hum Pathol2007，38，10：	1
17	Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma显示文摘	Patard J J Fergelot P Karakiewicz P I	2008	Int J Cancer2008，123，2：	1
18	Prognostic value of thrombocytosis in renal cell carcinoma显示文摘	Bensalah K Leray E Fergelot P	2006	J Urol2006，175，31：	1
19	Update on the Medical Treatment of Metastatic Renal Cell Carcinoma显示文摘	Alain Ravaud Hervé Wallerand Stéphane Culine Jean-Christophe Bernhard Patricia Fergelot Karim Bensalah Jean-Jacques Patard	2008	European Urology2008，，2：	1
20	Loss of expression of TIMP3 in clear cell renal cell carcinoma显示文摘	Masson D Rioux-Leclercq N Fergelot P	2010	Eur J Cancer2010，46，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示